Featured Satellite Educational Symposium
From Innovation to Implementation: Unlocking the Full Potential of Antibody-Drug Conjugates in Solid Tumors
Details
April 27 at 6:15 pm – 8:15 pm CDT
Hyatt Regency McCormick Place, Regency Ballroom AB
Organized By PVI, PeerView Institute for Medical Education
Speakers
Moderator: Sara A. Hurvitz, MD, FACP
University of Washington Medicine
Fred Hutchinson Cancer Center
Seattle, Washington
Presenter: Stephen V. Liu, MD
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, District of Columbia
Presenter: Funda Meric-Bernstam, MD
Institute of Personalized Cancer Therapy
The University of Texas MD Anderson Cancer Center
Houston, Texas
Presenter: Kathleen N. Moore, MD, MS
Stephenson Cancer Center at the University of Oklahoma HSC
Oklahoma City, Oklahoma
Event Description
Unlock the future of ADC therapy with PeerView Live in person in Chicago or virtually! Join our panel of top experts for a deep dive into the evolving role of ADCs in solid tumors. This dynamic session will cover the latest trial data on diverse ADC modalities in breast, lung, GI, GU, and other cancers, along with current and emerging biomarker strategies, practicalities of individualized patient and treatment selection, detection and management of a unique spectrum of adverse events, and new research directions. Don’t miss this opportunity to stay current on ADC approaches moving in leaps and bounds toward expanding the oncology treatment arsenal and improving patient outcomes across solid tumors—register now to save your spot and join the discussion!
This symposium is sponsored by PVI, PeerView Institute for Medical Education and supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc. This is not an official program of the American Association for Cancer Research Annual Meeting.